Post-earnings recap
Reported
Tue, Apr 20, 2010
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported a slight beat on EPS, which led to a positive stock reaction, increasing by 1.01%. The company did not provide any revenue figures or future guidance, leaving investors to focus on the earnings beat. Management's commentary suggests a focus on innovation, which could be a positive signal for future growth.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.80 | N/A | +1.01% |
Management expressed satisfaction with the earnings performance, particularly in EPS. They emphasized their commitment to innovation and customer satisfaction.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and meeting customer needs.